Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Celltrion Signs ‘Incubation’ Agreement with Emory University for Development of New Drugs for Atherosclerosis

Celltrion Inc. signed an ‘Incubation’ agreement with Emory University in Atlanta to support the research and development of new drug candidates for atherosclerosis.

Read More »

Roche names Pao head of drugs research and early development

Roche named U.S. cancer expert William Pao head of the Swiss drugmaker’s Pharma Research and Early Development business after John Reed decided to leave for what it called personal reasons.

Read More »

AHF Supports Development of Implant to Deliver HIV Drugs

LOS ANGELES–(BUSINESS WIRE)–Today AIDS Healthcare Foundation President Michael Weinstein issued the following statement on findings recently published in the Antimicrobial Agents and Chemotherapy report that scientists from the Oak Crest Institute of Science have created the first subdermal implant that delivers antiretroviral drugs for up to 40 days to prevent or treat HIV: “Numerous medical […]

Read More »

Atomwise Enters Three Joint Ventures to Use AI Platform for Drug Development

San Francisco-based Atomwise, a company focused on using artificial intelligence for drug discovery, signed three new deals.

Read More »

AstraZeneca Bolsters Machine Learning for Drug Development with Schrödinger Deal

AstraZeneca struck a deal to use Schrödinger’s advanced computing platform to help accelerate drug discovery efforts.

Read More »

Seeking Small Molecule Drugs to Control mRNA Translation

Anima Biotech technology uses state-of-the-art molecular biology that can illuminate the protein synthesis process and identify small molecules that regulate mRNA translation.

Read More »

Novo Nordisk’s new diabetes, obesity drugs lift sales outlook

Novo Nordisk’s sales forecast for 2019 was raised due to growing demand for obesity products and a new injectable treatment for diabetes, which is now the company’s growth engine as insulin sales decline.

Read More »

Ashfield Commercial and Patient Solutions appoints President of Global Business Development

Ashfield, part of UDG Healthcare plc, appointed George Esgro as President of Global Business Development for Ashfield Commercial and Patient Solutions.

Read More »

Key Lung Cancer Drugs Kept Off WHO’s Essential Medicines List

Immunotherapies that have emerged as a breakthrough in treating lung cancer were rejected for inclusion on the World Health Organization’s list of “essential medicines.”

Read More »

U.S. Companies Continue to Pay More in Healthcare as the Cost of Drugs Keeps Rising

The United States pays more per capita for prescription drugs than any other country in the world, which is a huge concern for patients and insurance providers.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!


Ad Right Bottom